Symptoms Alzheimer’s disease manifests itself in a continuously progressive loss of memory and mental and cognitive abilities. Possible symptoms of the disease include: Disorders and loss of memory. Initially, mainly short-term memory is affected (learning new things), later long-term memory is also affected. Forgetfulness, confusion Disorientation Speech, perception and thinking disorders, motor disorders. Personality change, … Alzheimer’s
Products Oligomannate was approved in China in 2019 in the form of capsules (Shanghai Green Valley Pharmaceuticals). The group led by Prof. Geng Meiyu at the Shanghai Institute of Materia Medica spent more than 20 years on the research. This is the first new oral Alzheimer’s drug since 2003, and another Phase III clinical trial … Oligomannate
Products Aducanumab has been studied in phase III trials and is in the pre-approval phase. The drug is not yet commercially available. The trials were discontinued in March 2019. However, following a re-analysis, the company announced in October 2019 that it expected to file for approval. Apparently, a sufficiently high dose is required for an … Aducanumab
